Ron Baron acquired 18 Thousand Vertex Pharmaceuticals shares worth $7.65 Million. That's 0.02% of their equity portfolio (216th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2017. Since then Ron Baron bought shares eleven more times and sold shares on seven occasions. The stake costed the investor $5 Million, netting the investor a gain of 53% so far.